GEODIS Expert David Frouin Outlines Cold Chain Packaging Qualification Strategies For Every Lane

Cold chain logistics remains one of the most technically demanding disciplines in pharmaceutical supply chain management, requiring precise packaging decisions at every stage.

GEODIS’ David Frouin has emerged as a key voice in the conversation around qualifying cold chain packaging solutions that meet the demands of diverse shipping lanes.

Packaging qualification is not a one-size-fits-all process, as different lanes and durations impose vastly different thermal and logistical pressures on pharmaceutical shipments.

The selection of appropriate cold chain packaging depends heavily on the specific lane characteristics, including transit time, climate zones, and the number of handling touchpoints involved.

Manufacturers face a growing range of options when specifying packaging for temperature-sensitive products, spanning reusable systems, single-use solutions, and fully active thermal technologies.

At LogiPharma USA 2026, Cold Chain Technologies’ Vijay Paliwal addressed how manufacturers should choose between reusable, single-use, and active packaging based on lanes and duration.

Active packaging systems, which use powered or phase-change mechanisms to maintain temperature, are typically reserved for longer or higher-risk lanes where passive solutions may fall short.

Single-use packaging offers simplicity and reduced contamination risk, making it a practical choice for shorter lanes or situations where return logistics are cost-prohibitive.

Reusable systems, while requiring more complex reverse logistics management, can deliver significant cost and sustainability benefits over high-volume, well-established trade lanes.

Qualifying packaging for each lane requires rigorous testing protocols that simulate real-world conditions, including seasonal temperature variations and worst-case handling scenarios.

The pharmaceutical industry continues to face increasing regulatory scrutiny over cold chain integrity, making robust qualification processes a commercial as well as a compliance necessity.

As global pharmaceutical distribution networks grow more complex, experts like Frouin and Paliwal are helping manufacturers build more resilient and lane-specific cold chain packaging strategies.